DMIIU

Drugs Made In America Acquisition II Corp Unit
DMIIU

71 hedge funds and large institutions have $429M invested in Drugs Made In America Acquisition II Corp Unit in 2025 Q3 according to their latest regulatory filings, with 71 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
71
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
HCM
26
Heights Capital Management
California
$5.17M
TAL
27
TIG Advisors LLC
New York
$4.97M
HI
28
HBK Investments
Texas
$4.97M
WRBC
29
W.R. Berkley Corp
Connecticut
$4.93M
WA
30
Whitebox Advisors
Minnesota
$4.48M
Verition Fund Management
31
Verition Fund Management
Connecticut
$4.48M
KPF
32
K2 Principal Fund
Ontario, Canada
$4.24M
RCM
33
Rivernorth Capital Management
Florida
$3.98M
COPPSERS
34
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$3.98M
MSU
35
Mizuho Securities USA
New York
$3.79M
Parallax Volatility Advisers
36
Parallax Volatility Advisers
California
$3.7M
CS
37
Clear Street
New York
$3.55M
Toronto Dominion Bank
38
Toronto Dominion Bank
Ontario, Canada
$3.48M
SCM
39
Steadfast Capital Management
New York
$2.98M
SAMU
40
SONA Asset Management (US)
New York
$2.98M
LIP
41
Lighthouse Investment Partners
Florida
$2.98M
AGM
42
Alpine Global Management
New York
$2.98M
PC
43
Periscope Capital
Ontario, Canada
$2.49M
MTCM
44
Mint Tower Capital Management
Netherlands
$2.49M
WCMNY
45
Westchester Capital Management (New York)
New York
$1.99M
SCM
46
Saba Capital Management
New York
$1.98M
GCIA
47
Gabelli & Co Investment Advisers
New York
$1.55M
SG
48
StoneX Group
New York
$1.49M
GF
49
Gabelli Funds
New York
$1.36M
SSA
50
Schonfeld Strategic Advisors
New York
$1.29M